Article
Activity of ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, cefiderocol and comparators against Gram-negative organisms causing bloodstream infections in Northern Italy (2019-2021): emergence of complex resistance phenotypes.
Journal of chemotherapy (Florence, Italy) - 1 Sept 2022
Bianco Gabriele, Boattini Matteo, Comini Sara, Iannaccone Marco, Casale Roberto, Allizond Valeria, Barbui Anna Maria, Banche Giuliana, Cavallo Rossana, Costa Cristina
Abstract excerpt
Herein we assessed the frequency of Gram-negative organisms causing bloodstream infections and activity spectrum of ceftolozane-tazobactam (CTZ), ceftazidime-avibactam (CZA), meropenem-vaborbactam (MEV), cefiderocol (CFDC) and comparators. Overall, 1605 Gram-negative isolates were consecutively collected during 2019-2021. Enterobacterales represented more than 75% and exhibited >90% susceptibility to CZA (97%),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.